Vesalius Biocapital Fund III raises $72.3 mln in first close

Vesalius Biocapital said May 18 that a first close of its third fund has secured more than 65 million euros ($72.3 million) in commitment. Vesalius Biocapital III has a 150 million euro ($167 million) target. Vesalius Biocapital III will focus on later-stage European companies in drug development, medtech, diagnostics and eHealth / mHealth.

FundraisingManagersNorth AmericaUSFundraisingBriefs